Guided by science, we are relentlessly committed to bringing transformative new medicines to patients with oncogene amplified cancer. Requisite to our success are boldness, creativity, and collaboration.
United in purpose, we are a team of experienced precision oncology leaders with deep scientific, clinical, diagnostic, and business expertise. We are applying this experience to develop an entirely new vertical of cancer therapeutics, ecDNA-directed therapies (ecDTx).
At Boundless, we’re all in. We are unbound by convention, bound to save lives.
